Passage Bio Inc
NASDAQ:PASG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
FVCBankcorp Inc
NASDAQ:FVCB
|
US |
|
Enovix Corp
NASDAQ:ENVX
|
US |
|
U
|
United Parcel Service Inc
F:UPAB
|
US |
|
P
|
Pfizer Inc
SIX:PFE
|
US |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
U
|
Unum Group
F:UUM
|
US |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
Lifeline SPAC I Oyj
F:0CD
|
FI |
|
A
|
Apollo Investment Corp
F:55O1
|
US |
|
S
|
Swire Pacific Ltd
XBER:SWI
|
HK |
|
K
|
Konami Holdings Corp
F:KOA
|
JP |
Wall St Price Targets
PASG Price Targets Summary
Passage Bio Inc
According to Wall Street analysts, the average 1-year price target for
PASG is 15.81 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PASG's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
PASG is 15.81 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.